Illinois15th Congressional District

The bill trades improved health-aligned coordination and immediate operational continuity (staff, funds, and regulations moving to HHS) for short-term administrative disruption, potential shifts away from educational priorities, legal ambiguity, and budgetary/accounting constraints during the transition.

1. house
3. senate
5. president

The bill increases transparency, preservation, and inter-branch oversight of congressional records but does so at the cost of some legal-transition risks and recurring administrative time and expense.

1. house
3. senate
5. president

The bill increases visibility of the national motto in federal buildings—strengthening civic symbolism and creating modest short-term contractor work—while imposing modest costs on taxpayers and administrative burdens on GSA.

1. house
3. senate
5. president

The bill increases parental notification, involvement, and legal enforcement for unemancipated minors seeking abortion while preserving a narrow emergency exception and state authority, but it also creates delays, legal burdens, confidentiality risks, and criminal penalties that may reduce access and put some minors at increased risk.

1. house
3. senate
5. president

The bill increases in-person oversight and medical-waste safeguards for chemical abortion care but does so by restricting telemedicine and imposing broad criminal definitions that are likely to reduce access, raise costs, create provider uncertainty, and prompt more federal enforcement.

1. house
3. senate
5. president

The bill preserves individual choice over fetal-tissue disposition and creates uniform federal reporting useful for policy, but pairs those benefits with strict disposal and documentation mandates carrying heavy penalties, privacy risks, and increased compliance costs that could deter providers and reduce access.

1. house
3. senate
5. president

The bill standardizes informed consent and preserves emergency exceptions, but imposes heavy legal, financial, privacy, and procedural burdens that are likely to delay care and substantially reduce access to abortion services.

1. house
3. senate
5. president

The bill creates a federally run hotline and mandated labeling intended to increase post-mifepristone support and information, but it risks substituting congressional claims for FDA science, creating medical confusion, narrowing referral choices, and imposing costs on manufacturers and taxpayers.

1. house
3. senate
5. president

This bill seeks to void certain FDA approvals tied to treating pregnancy as an illness — which would curb access to medication abortion and create significant health, cost, legal, and supply-chain harms for patients and providers, while offering limited, primarily ideological benefits to those who oppose abortion.

1. house
3. senate
5. president